1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32 | Continued from 9099-C
In addition, floor alarm mats were placed on the floor around R1’s bed at night to alert the night staff if R1 got out of bed without contacting them for help. The overnight staff spent the night in a chair outside R1’s room, which allowed them to respond in a prompt manner to incidents or accidents that might occur in the residents’ rooms. The staff working on the night of R1’s fall properly responded as well as assessed R1 after the fall and 911 was called when R1 reported pain. Interviews were conducted with R1’s resident representatives, R1, facility residents and staff. The information obtained during the Department’s investigation did not sufficiently support the allegation. While R1 did sustain a fall which resulted in a fracture, the investigation did not provide sufficient evidence to substantiate neglect/lack of supervision. Therefore, the allegation is deemed Unsubstantiated at this time.
It was reported that “Staff mismanaged resident’s medication” as it was alleged that the Administrator was administering medications that were discontinued. Interviews and record reviews revealed that on 02/07/2025, R1 was admitted to Los Robles Regional Medical Center. The discharge orders directed to stop administering the medication Amlodipine Besylate (NORVASC 5 mg) daily and to consider resuming blood pressure medication only if systolic blood pressure exceeded 160–170 mmHg. On 02/24/2025, R1 was admitted to Kaiser for hypertension and mild chronic kidney disease. The Primary Care Physician (PCP) ordered R1 to start Amlodipine for blood pressure control. On 02/25/2025, during a scheduled visit at the Kaiser Geriatric Clinic, R1 was discharged with instructions to stop taking Amlodipine. Between 02/26 - 03/06/2025, R1’s blood pressure readings were as follows: 149/88, 164/88, 172/80, 167/81, 157/83, 149/89, 164/89, 156/90, and 168/90. On 03/06/2025, the facility administrator notified R1’s PCP of these readings. The PCP recommended restarting Amlodipine. According to the administrator’s interview, the facility requested the POA to order and provide the medication, as has been done in the past. The POA declined to order Amlodipine, citing the 02/07/2025 recommendation from Los Robles advising against its use. As a result, R1 did not receive Amlodipine from March 6 until March 11, 2025, when R1 relocated from the facility. Medication Administration Records (MARs) confirm that R1 was not administered Amlodipine from February 7 through March 11, 2025. Based on the information obtained during the investigation, the Department does not have sufficient evidence to corroborate the allegation. Although the allegation may have happened or is valid, there is not a preponderance of evidence to prove the alleged violations did or did not occur, therefore the above allegation “Staff mismanaged resident’s medication” is deemed Unsubstantiated at this time. |